![Brian Price](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brian Price
Keine laufenden Positionen mehr
Karriereverlauf von Brian Price
Ehemalige bekannte Positionen von Brian Price
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Myonexus Therapeutics, Inc.
![]() Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Corporate Officer/Principal | 01.08.2018 | 01.03.2019 |
Blue Water Biotech, Inc.
![]() Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Geschäftsführer | - | 15.08.2020 |
Corporate Officer/Principal | 15.08.2020 | - |
Ausbildung von Brian Price
The Ohio State University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Blue Water Biotech, Inc.
![]() Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Health Technology |
Myonexus Therapeutics, Inc.
![]() Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Health Technology |
- Börse
- Insiders
- Brian Price
- Erfahrung